Progress in the understanding of polycystic kidney disease
Open accessThe DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
The function of polycystin proteins and the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) are not well understood. Studies published in 2018 made important contributions to the understanding of genetic mechanisms, the structure of the polycystin complex and the roles of G-protein signalling and the immune system in ADPKD.Key advancesThe identification of high levels of somatic mutations in PKD1 and PKD2 in autosomal dominant polycystic kidney disease (ADPKD) cysts demonstrates an important role of polycystin loss in cyst progression1.A high-resolution cryogenic electron microscopy structure of the polycystin 1–polycystin 2 (PC1–PC2) complex provides insights into polycystin function and suggests that this complex does not form a functional Ca2+ permeable channel2.PC1 acts as a G-protein coupled receptor (GPCR) that binds α subunits; loss of the G-protein binding domain of PC1 causes GPCR hyper-reactivity, suggesting possible treatment options for ADPKD3.Cilia actively promote chemokine signalling and inflammation via a pathway that promotes monocyte chemoattractant protein 1 (MCP1) expression; this pathway can be suppressed by a module involving LKB1, PC1 and nephronophthisis-associated proteins4.Expression of MCP1 promotes macrophage accumulation and cystic dilatation; blocking the MCP1 receptor might be an advantageous strategy for the treatment of ADPKD5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Polycystic kidney disease (PKD) is the most common genetic form of CKD and is characterized by the development and growth of multiple kidney cysts, which leads to kidney damage and can cause kidney failure171.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [171]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the human PKD1-PKD2 complex
Su, Q., Hu, F., Ge, X., Lei, J., Yu, S., Wang, T., Zhou, Q., Mei, C., & Shi, Y. (2018) · Science · doi:10.1126/science.aat9819 · Cited by 284
The Structure of the Polycystic Kidney Disease Channel PKD2 in Lipid Nanodiscs
Shen, P. S., Yang, X., DeCaen, P. G., Liu, X., Bulkley, D., Clapham, D. E., & Cao, E. (2016) · Cell · doi:10.1016/j.cell.2016.09.048 · Cited by 252
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease
Cassini, M. F., Kakade, V. R., Kurtz, E., Sulkowski, P., Glazer, P., Torres, R., Somlo, S., & Cantley, L. G. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018050518 · Cited by 112
Viau, A., Bienaimé, F., Lukas, K., Todkar, A. P., Knoll, M., Yakulov, T. A., Hofherr, A., Kretz, O., Helmstädter, M., Reichardt, W., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798615 · Cited by 104
Trujillano, D., Bullich, G., Ossowski, S., Ballarín, J., Torrá, R., Estivill, X., & Ars, E. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.82 · Cited by 89
Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease
Tan, A. Y., Zhang, T., Michaeel, A., Blumenfeld, J. D., Liu, G., Zhang, W., Zhang, Z., Zhu, Y., Rennert, L., Martin, C., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017080878 · Cited by 69
Messchendorp, A. L., Meijer, E., Boertien, W. E., Engels, G. E., Casteleijn, N. F., Spithoven, E. M., Losekoot, M., Burgerhof, J. G. M., Peters, D. J. M., & Gansevoort, R. T. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.10.004 · Cited by 48
A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD
Parnell, S. C., Magenheimer, B. S., Maser, R. L., Pavlov, T. S., Havens, M. A., Hastings, M. L., Jackson, S. F., Ward, C. J., Peterson, K. R., Staruschenko, A., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy223 · Cited by 46
Zhang, B., Tran, U., & Wessely, O. (2018) · Development · doi:10.1242/dev.158931 · Cited by 35
Grantham, J. J., Chapman, A. B., Blais, J. D., Czerwiec, F. S., Devuyst, O., Gansevoort, R. T., Higashihara, E., Krasa, H. B., Zhou, W., Ouyang, J., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw060 · Cited by 31
Self-citation
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Ciliopathies and the Kidney: A Review
McConnachie, D. J., Stow, J. L., & Mallett, A. J. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.08.012 · Cited by 257
“This is supported by the focal and monoclonal nature of the renal cysts that are thought to occur following reduction in levels of PC1 and PC2 below a critical threshold, though this is somewhat debated.(62,63) A myriad of effector pathways lie downstream of the polycystin complex, including canonical Wnt/β-catenin an…”
BackgroundSTAT signaling in polycystic kidney disease
Strubl, S., Torres, J. A., Spindt, A. K., Pellegrini, H., Liebau, M. C., & Weimbs, T. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109639 · Cited by 35
Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances
Borghol, A. H., Antoun, M. T. B., Hanna, C., Salih, M., Rahbari-Oskoui, F. F., & Chebib, F. T. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2492374 · Cited by 23
Mechanical protein polycystin-1 directly regulates osteoclastogenesis and bone resorption
Huang, M., Zhou, J., Li, X., Liu, R., Jiang, Y., Chen, K., Jiao, Y., Yin, X., Liu, L., Sun, Y., et al. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.04.044 · Cited by 22
“Loss-of-function mutations of PKD1in mice [29–32] and humans [33–35] not only cause renal cystic diseases but also result in abnormally low bone turnover, indicating a deficiency in bone remodeling.”
Background
Metadata
- Authors
- Torres, V. E., & Harris, P. C.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Torres, Vicente E.
- Harris, Peter C.
- Venue
- Nature Reviews Nephrology
- Published
- 2019-01-03
- Volume
- 15
- Issue
- 2
- Pages
- 70-72
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- PMC
- PMC6543819
- OpenAlex
- W2906994584
- Cited by
- 53
- References
- 11
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 18 · 2022: 9 · 2021: 5 · 2020: 6
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK044863, P30DK090728)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- autosomal dominant polycystic kidney disease, G protein signaling, immune system, genetic mechanisms, pathogenesis
- MeSH terms
- Genetic Markers, Humans, Mutation, Signal Transduction, Biomarkers, Polycystic Kidney, Autosomal Dominant, GTP-Binding Proteins, TRPP Cation Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress in the understanding of polycystic kidney disease. https://app.cochat.ai/papers/10.1038/s41581-018-0108-1
- The paper
- Torres, V. E., & Harris, P. C. (2019). Progress in the understanding of polycystic kidney disease. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-018-0108-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.